Your account is not claimed yet. You can sign up with ORCID to claim your account.

Tao Zhu

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 7

Top Venues

Cell death & disease

Cancer research

Oncogenesis

Nature nanotechnology

University of Science and Technology of China

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Science and Technology of China

China

Professor :: Cell Biology

Publications

Xi Zhang, Liqiong Wang, Shu Chen, Peng Huang, Lan Ma, Hui Ding, Basappa Basappa, Tao Zhu, Peter E Lobie, Vijay Pandey
Combined inhibition of BADSer99 phosphorylation and PARP ablates models of recurrent ovarian carcinoma. Communications medicine 2 (2022)
Mingming Wu, Xiao Zhang, Weijie Zhang, Yi-Shiou Chiou, Wenchang Qian, Xiangtian Liu, Min Zhang, Hong Yan, Shilan Li, Tao Li, Xinghua Han, Pengxu Qian, Suling Liu, Yue-Yin Pan, Peter E Lobie, Tao Zhu
Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis. Nature communications 13 (1) (2022)
Feifei Cheng, Xuejuan Wang, Yi-Shiou Chiou, Chuyu He, Hui Guo, Yan Qin Tan, Basappa Basappa, Tao Zhu, Vijay Pandey, Peter E Lobie
Trefoil factor 3 promotes pancreatic carcinoma progression via WNT pathway activation mediated by enhanced WNT ligand expression. Cell death & disease 13 (3) (2022)
Qianying Guo, Hao Wang, Jiahao Duan, Wenwu Luo, Rongrong Zhao, Yuting Shen, Bijun Wang, Siqi Tao, Yi Sun, Qian Ye, Xiaomin Bi, Hui Yuan, Qiang Wu, Peter E Lobie, Tao Zhu, Sheng Tan, Xing Huang, Zheng-Sheng Wu
An Alternatively Spliced p62 Isoform Confers Resistance to Chemotherapy in Breast Cancer. Cancer research 82 (21) (2022)
Xi Zhang, Peng Huang, Liqiong Wang, Shu Chen, Basappa Basappa, Tao Zhu, Peter E Lobie, Vijay Pandey
Inhibition of BAD-Ser99 phosphorylation synergizes with PARP inhibition to ablate PTEN-deficient endometrial carcinoma. Cell death & disease 13 (6) (2022)
Mengyi Zhang, Baocheng Wang, Qing-Yun Chong, Vijay Pandey, Zhirong Guo, Ru-Mei Chen, Lingzhi Wang, Yanxin Wang, Lan Ma, Alan P Kumar, Tao Zhu, Zheng-Sheng Wu, Zhinan Yin, null Basappa, Boon-Cher Goh, Peter E Lobie
A novel small-molecule inhibitor of trefoil factor 3 (TFF3) potentiates MEK1/2 inhibition in lung adenocarcinoma. Oncogenesis 8 (11) (2019)
Xuefei Lu, Yong Zhu, Ru Bai, Zhengsheng Wu, Wenchang Qian, Leiyan Yang, Rong Cai, Hong Yan, Tao Li, Vijay Pandey, Ying Liu, Peter E Lobie, Chunying Chen, Tao Zhu
Long-term pulmonary exposure to multi-walled carbon nanotubes promotes breast cancer metastatic cascades. Nature nanotechnology 14 (7) (2019)

Tao Zhu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tao Zhu